> top > docs > PMC:7212965 > spans > 36749-37623 > annotations

PMC:7212965 / 36749-37623 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T79 33-38 Body_part denotes Liver http://purl.org/sig/ont/fma/fma7197
T80 309-315 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T81 611-616 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T61 33-38 Body_part denotes Liver http://purl.obolibrary.org/obo/UBERON_0002107
T62 611-616 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T174 58-66 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T175 167-175 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T176 390-398 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T177 679-687 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T289 33-38 http://purl.obolibrary.org/obo/UBERON_0002107 denotes Liver
T290 33-38 http://www.ebi.ac.uk/efo/EFO_0000887 denotes Liver
T291 185-188 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T292 309-315 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T293 351-354 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T294 463-475 http://purl.obolibrary.org/obo/OBI_0000245 denotes Organization
T295 492-493 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T296 572-575 http://purl.obolibrary.org/obo/PR_000001343 denotes aim
T297 587-588 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T298 611-616 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T299 611-616 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T57 260-278 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T58 280-290 Chemical denotes remdesivir http://purl.obolibrary.org/obo/CHEBI_145994
T59 339-350 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T60 745-747 Chemical denotes GI http://purl.obolibrary.org/obo/CHEBI_73907

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T229 0-78 Sentence denotes What Are Common Gastrointestinal/Liver Adverse Effects of COVID-19 Treatments?
T230 79-176 Sentence denotes `There are currently no US Food and Drug Administration–approved routine treatments for COVID-19.
T231 177-399 Sentence denotes The FDA has issued an emergency use authorization for 3 therapies: choloroquine or hydroxychloroquine, remdesivir, and convalescent plasma.82 In China and Japan, favipiravir has been approved for the treatment of COVID-19.
T232 400-733 Sentence denotes Numerous medications are under investigation; the World Health Organization is spearheading a multinational, multicenter trial for the 5 treatments highlighted below.83 We aim to provide a summary of the Gl and liver adverse effects of the most commonly utilized medications for COVID-19 at this time, irrespective of their efficacy.
T233 734-874 Sentence denotes Medication GI-related adverse events are summarized in Supplementary Tables 1 and 2 (direct evidence sources and indirect evidence sources).

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
924 16-32 Gene denotes Gastrointestinal Gene:2770
925 58-66 Disease denotes COVID-19 MESH:C000657245
934 745-747 Gene denotes GI Gene:2770
935 244-256 Chemical denotes choloroquine
936 260-278 Chemical denotes hydroxychloroquine MESH:D006886
937 280-290 Chemical denotes remdesivir MESH:C000606551
938 339-350 Chemical denotes favipiravir MESH:C462182
939 167-175 Disease denotes COVID-19 MESH:C000657245
940 390-398 Disease denotes COVID-19 MESH:C000657245
941 679-687 Disease denotes COVID-19 MESH:C000657245